Search / Trial NCT06616610

Single-Button Mobility Platform's Effect on Reaction Time and Keystroke Accuracy in Children with Cerebral Palsy

Launched by UNIVERSITY OF SEVILLE · Sep 25, 2024

Trial Information

Current as of October 03, 2024

Completed

Keywords

Cerebral Palsy Children Reaction Time Mobility Platform Cognitive Development Gmfcs Levels Iv V Motor Skills

Description

The experimental timeline includes eight weekly sessions, each lasting 30 minutes. Initially, therapists will receive an explanation on how to use the platform and the accompanying configuration application. They will familiarize themselves with it a couple of weeks before the experiment begins. During the sessions, children in the experimental group will use the platform, while those in the control group will continue receiving their traditional therapy. Researchers will pre-adjust the children\'s interactions to match the platform variables, allowing for meaningful comparisons. Thera...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Diagnosed with cerebral palsy
  • * Classified as GMFCS level IV or higher, indicating an inability to walk or operate a powered wheelchair.
  • * Under 12 years old.
  • * Must be affiliated to a center whose facilities guarantee a proper navigation experience
  • Exclusion Criteria:
  • - Inability to act on an actuator (Start button)

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Seville, Andalucia, Spain

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0